Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

5.82USD
23 May 2018
Change (% chg)

$-0.01 (-0.17%)
Prev Close
$5.83
Open
$5.78
Day's High
$5.98
Day's Low
$5.78
Volume
34,582
Avg. Vol
141,119
52-wk High
$7.68
52-wk Low
$4.41

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.04 0.10 0.00 --
Quarter Ending Sep-18 4 0.04 0.10 0.00 --
Year Ending Dec-18 5 0.18 0.40 0.12 3.88
Year Ending Dec-19 7 2.27 15.18 0.00 35.43
Earnings (per share)
Quarter Ending Jun-18 4 -0.16 -0.12 -0.19 --
Quarter Ending Sep-18 4 -0.19 -0.16 -0.21 --
Year Ending Dec-18 5 -0.67 -0.56 -0.79 -0.44
Year Ending Dec-19 6 -0.62 -0.19 -0.93 -0.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta -- 0.90 0.88
Price to Sales (TTM) -- 110.95 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) -- 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions -- 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.86 5.69
Sales - 5 Yr. Growth Rate -- 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) -- 5.29 2.98
LT Debt to Equity (MRQ) -- 22.98 12.17
Total Debt to Equity (MRQ) -- 24.63 16.44
Interest Coverage (TTM) -- -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.09 10.96
Operating Margin (TTM) -- -718.94 4.73
Operating Margin - 5 Yr. Avg. -- -596.41 6.40
Pre-Tax Margin (TTM) -- -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.76 6.82
Net Profit Margin (TTM) -- -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,637,573 847,034,055
Net Income/Employee (TTM) -- 2,973,815 99,640,144
Receivable Turnover (TTM) -- 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) -- 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.09 10.95
Return on Assets - 5 Yr. Avg. -- -0.58 12.32
Return on Investment (TTM) -- 1.57 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.11
Return on Equity (TTM) -- 2.43 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.